Lee Josephson
Corporate Officer/Principal presso Harvard Medical School
Profilo
Lee Josephson is the founder of T2 Biosystems, Inc. (founded in 2006).
He is currently an Associate Professor at Harvard Medical School.
Dr. Josephson previously worked as a Director-Probe Chemistry at The General Hospital Corp.
and as a Principal at the Center for Translational Molecular Medicine.
He received his undergraduate degree from the University of Wisconsin and his doctorate from The State University of New York.
Dr. Josephson is also the founder of AMAG Pharmaceuticals, Inc.
Posizioni attive di Lee Josephson
| Società | Posizione | Inizio |
|---|---|---|
| Harvard Medical School | Corporate Officer/Principal | 07/04/2011 |
Precedenti posizioni note di Lee Josephson
| Società | Posizione | Fine |
|---|---|---|
The General Hospital Corp.
 The General Hospital Corp. Hospital/Nursing ManagementHealth Services The General Hospital Corp. provides healthcare services. It offers diagnostic and therapeutic are in every specialty and subspecialty of medicine and surgery. The firm's care center provides cancer, digestive disorders, heart disease, transplantation and vascular medicine services. The company was founded in 1811 and is headquartered in Boston, MA. | Corporate Officer/Principal | - |
| AMAG PHARMACEUTICALS, INC. | Fondatore | - |
Center for Translational Molecular Medicine
 Center for Translational Molecular Medicine BiotechnologyHealth Technology The Center for Translational Molecular Medicine provides molecular science research services. The non-profit company is based in Eindhoven, Netherlands. and has subsidiaries in Netherlands. | Corporate Officer/Principal | - |
| T2 BIOSYSTEMS, INC. | Fondatore | - |
Formazione di Lee Josephson
| University of Wisconsin | Undergraduate Degree |
| The State University of New York | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| T2 BIOSYSTEMS, INC. | Health Technology |
| Aziende private | 3 |
|---|---|
AMAG Pharmaceuticals, Inc.
 AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. Its products include Makena and Feraheme. It focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It also manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. The company was founded on November 9, 1981 and is headquartered in Waltham, MA. | Health Technology |
Center for Translational Molecular Medicine
Center for Translational Molecular Medicine BiotechnologyHealth Technology The Center for Translational Molecular Medicine provides molecular science research services. The non-profit company is based in Eindhoven, Netherlands. and has subsidiaries in Netherlands. | Health Technology |
The General Hospital Corp.
The General Hospital Corp. Hospital/Nursing ManagementHealth Services The General Hospital Corp. provides healthcare services. It offers diagnostic and therapeutic are in every specialty and subspecialty of medicine and surgery. The firm's care center provides cancer, digestive disorders, heart disease, transplantation and vascular medicine services. The company was founded in 1811 and is headquartered in Boston, MA. | Health Services |
- Borsa valori
- Insiders
- Lee Josephson
